Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 179688-53-0 | MDL No. : | MFCD09833010 |
Formula : | C11H10N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SOLQIFINSOHAQD-UHFFFAOYSA-N |
M.W : | 234.21 | Pubchem ID : | 135681960 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.18 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 60.35 |
TPSA : | 81.28 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.42 cm/s |
Log Po/w (iLOGP) : | 1.44 |
Log Po/w (XLOGP3) : | 0.43 |
Log Po/w (WLOGP) : | 0.86 |
Log Po/w (MLOGP) : | 0.81 |
Log Po/w (SILICOS-IT) : | 1.92 |
Consensus Log Po/w : | 1.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.8 |
Solubility : | 3.71 mg/ml ; 0.0158 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.7 |
Solubility : | 4.63 mg/ml ; 0.0198 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.45 |
Solubility : | 0.0837 mg/ml ; 0.000357 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.03 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | at 180℃; for 4 h; | 6,7-Dihydroxyquinazolinone (2) To an excess of stirred molten pyridinium hydrochloride at 180 °C was added portionwise 6-acetoxy-7-methoxy-quinazolone (1) (49.5 g, 211.35 mmol) and the resulting solution was stirred at 180 °C for 4 hours. After cooling to room temperature, water (500 ml) was added and the pH adjusted to 7 with aqueous ammonia. The resulting precipitate was collected by filtration, washed with water (5 x 20 ml), ether (5 x 20 ml) and dried to a constant weight in a vacuum oven at 40 °C to afford 6,7-dihydroxyquinazolinone (2) (38 g, 100percent) as a beige solid: LCMS (retention time = 0.97 min., purity = 98percent), ESI+ m/z 179.18 (M+H)+; 'H- NMR (DMSO-d6) δ (ppm) 6.95 (s, 1H), 7.41 (s, 1H), 7.91 (s, 1H), 9.78 (s, 1H), 10.23 (s, 1H), 11.7 (br s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | at 100℃; for 4 h; | 6-hydroxy-7-methoxy-3H-quinazolin-4-one (1.92 g, 10 mmol) was added to acetic anhydride (20 mL)Pyridine (4 mL) was added with stirring,Heated at 100 ° C for 4 hours.After cooling to room temperature, add ice water quenching reaction,The precipitated white solid was the intermediate M-1 (2.32 g, 99percent) |
96.6% | at 100℃; for 2 h; | To the reaction vessel were added 6-hydroxy-7-methoxy-4 (3H) -quinazolinone (4.8 g, 25 mmol), 20 mL of acetic anhydride, pyridinehaeating upto 100 degree celcius for 2 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, the solvent was evaporated to dryness, and water was added to the residue to precipitate a solid. The resulting solid was washed with water, filtered and dried to give 6-ethoxycarbonyl-7-methoxy- Quinazolinone (2.26 g, yield 96.6percent |
93% | at 100℃; for 4 h; | Step 5. A mixture of product step 4 (30.5 mmol), acetic anhydride (21.5 mL, 229 mmol) and pyridine (4.9 mL, 61 mmol) was heated to 100°C for 4 h. After cooling to r.t., ice water (200 mL) was added and the mixture was vigorously stirred for 1 h. The precipitated 7-acetoxy-6-methoxy-3,4-dihydroquinazolin-4-one or 6-acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one, respectively, was filtered off, washed with water and dried (93-96percent). |
93% | at 100℃; for 4 h; | Step 5. A mixture of product step 4 (30.5 mmol), acetic anhydride (21.5 mL, 229 mmol) and pyridine (4.9 mL, 61 mmol) was heated to 100° C. for 4 h. After cooling to r.t., ice water (200 mL) was added and the mixture was vigorously stirred for 1 h. The precipitated 7-acetoxy-6-methoxy-3,4-dihydroquinazolin-4-one or 6-acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one, respectively, was filtered off, washed with water and dried (93-96percent). |
82% | at 116℃; for 3 h; | 6-Acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one was obtained according to W096/33980 in 82percent yield. The crude product was used for the next step without purification. |
75% | at 120 - 125℃; for 3 h; | Into a reaction flask, acetic anhydride (864g, 16.25 m.eq) followed by 6-hydroxy- 7-methoxy-quinazoline-4(3H)-one of formula-XII (lOOg; 1.0 m.eq) were added under stirring and heated the reaction mass to 120-125°C and maintained for about 3h. The progress of the reaction was monitored by TLC. After completion of reaction, cooled the reaction mass to 25-35°C and quenched in ice water (2000g) under stirring. The resulting product mixture was heated to 60-65°C, maintained for lh and cooled the reaction mass to 25-35°C and maintained under stirring for 2h. The resulting product was isolated by filtration and washed with water. The product was further purified by recrystallization from dimethylformamide to afford 6-acetoxy-7-methoxy-quinazoline-4(3H)-one of formula-XV as crystalline solid (90.0g; 75percent by theory). |
60% | at 100℃; for 4 h; | The 6-hydroxy-7-methoxy -3H quinazolin-4-one (4g, 0.021mol), acetic anhydride (30 ml), pyridine (5 ml) and DMAP (10 mg) is added to the 50 ml reaction flask, stirring and heating to 100 °C, reaction 4h, by adding ice water, filtered, ice water washing, to obtain white powdery solid, yield 60percent. |
53% | at 20 - 100℃; for 3 h; | To a suspension of 6-hydroxy-7-methoxyquinazolin-4(3H)-one (0.57 g) and pyridine (4 mL) was added acetic anhydride ( 10 mL) at room temperature. The reaction mixture was stirred at 100 °C for 3 hours, and then poured into ice-water. The resulting mixture was filtered to give the title compound (0.40 g, 53.00 percent). The compound was characterized by the following spectroscopic data: ? NMR (400 MHz, d6-DMSO) ?: 2.30 (s, 3H), 3.92 (s, 3H), 7.28 (s, 1 H), 7.75 (s, 1 H), 8.08 (s, 1 H). |
53% | at 100℃; for 3 h; | To a suspension of 6-hydroxy-7-methoxyquinazolin-4(3H)-one (0.57 g) and pyridine (4 mL) was added acetic anhydride (10 mL) at room temperature. The reaction mixture was stirred at 100° C. for 3 hours, and then poured into ice-water. The resulting mixture was filtered to give the title compound (0.40 g, 53.00percent). The compound was characterized by the following spectroscopic data: 1H NMR (400 MHz, d6-DMSO) δ: 2.30 (s, 3H), 3.92 (s, 3H), 7.28 (s, 1H), 7.75 (s, 1H), 8.08 (s, 1H). |
51% | at 100℃; for 6 h; | Add 6-hydroxy-7-methoxy-3H-quinazolin-4-one (1 g, 5.2 mmol) in a 50 mL round bottom flask, acetic anhydride(20mL) and pyridine (4mL), the system was reacted at 100 ° C for 6h,The TLC detection of the starting material was complete.The reaction system was cooled to room temperature, and the round bottom flask was placed in an ice water bath and stirred.The suspension was then transferred to a 500 mL round bottom flask.In an ice water bath, add 300 mL of ice water and stir for 20 minutes.A large amount of white solid precipitated. Filter by suction, then wash the filter cake twice with water.Drying in an oven, the obtained white solid is (7-methoxy-4-oxo-3,4-dihydroquinazoline)-6-yl-acetate, yield51percent. |
50% | for 3 h; Heating / reflux | A mixture of 6-hydroxy-7-methoxyquinazolin-4(3H)-one (0103) (1O g crude), acetic anhydride (100 ml) and pyridine (8ml) was stirred and heated to reflux for 3 hours. The mixture was cooled to room temperature and poured into a mixture (250ml) of ice and water. The precipitate was isolated and dried to yield the title product 0104 as a grey solid (5.8g, 50percent two step overall yield): LCMS: m/z 235[M+1]+; 1H NMR(CDCl31) δ 2.27 (s, 3H), 3.89 (s, 3H), 7.28 (s, IH), 7.72 (s, IH), 8.08 (d, IH), 12.20 (bs, IH). |
40% | at 100℃; for 6 h; Inert atmosphere | A suspension of compound 3 (3.88 g, 20.2 mmol), pyridine (4 mL) and DMAP (122 mg, 1.0 mmol) in acetic anhydride (30 mL) was heated to 100 °C and stirred under N2 atmosphere for 6 h. The reaction mixture was cooled and poured into ice-water. The resultant precipitate was filtered, washed with water and dried under vacuum to afford 4 (1.88 g, 40percent) as a beige solid, mp 303–305 °C. 1H NMR (DMSO-d6): d 12.2 (s, 1H), 8.09 (s, 1H), 7.75 (s, 1H), 7.28 (s, 1H), 3.91 (s,3H), 2.30 (s, 3H). LC-MS (ESI, m/z): calcd for C11H11N2O4 ([M+H]+) 235.1, found 235.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With pyridine In water; acetic anhydride | Step 2 7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate: Pyridine (3.95 g, 50.00 mmol, 2.00 equiv) was added to a solution of 6-hydroxy-7-methoxyquinazolin-4(3H)-one (4.8 g, 24.97 mmol, 1.00 equiv) in acetic anhydride (38 mL). The resulting solution was stirred at about 100° C. for about 4 hours, and then was poured into ice/water (200 ml). The resulting precipitate was isolated, washed with water, and dried in vacuo, to give the title product as a gray solid (2.7 g; yield=46percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | Stage #1: at 20 - 100℃; for 23.5 h; Stage #2: With sodium hydroxide In water Stage #3: at 100℃; for 1 h; |
a) A mixture of 6,7-dimethoxy-3,4-dihydroquinazolin-4-one (20.0 g, 97 mmol) and racemic methionine (21.7 g, 146 mmol) in methanesulphonic acid (150 ml) were heated at 100° C. for 5.5 hours and then allowed to cool to ambient temperature over 18 hours. The reaction was poured into cold water (750 ml), the pH of the aqueous solution was adjusted to pH 6 (by addition of 2.0N aqueous sodium hydroxide solution) and the solid which formed was collected by suction filtration. The solid was dried in vacuo and then dissolved in a mixture of pyridine (20 ml) and acetic anhydride (150 ml). The solution was heated at 100° C. for 1 hour, cooled and poured into cold water (1050 ml). Collection of the resultant solid by suction filtration, followed by drying in vacuo, yielded 6-acetoxy-7-methoxy-3,4-dihydro-quinazolin-4-one (13.9 g, 57percent yield) as a pale-brown solid: 1H-NMR (DMSO d6): 12.16 (s, 1H), 8.05 (s, 1H), 7.75 (s, 1H), 3.90 (s, 3H), 2.25 (s, 3H): MS (-ve ESI): 233 (M-H)-, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | Stage #1: at 120℃; for 24 h; Stage #2: at 100℃; for 22 h; |
To a solution of 8 (1.80 g, 8.73 mmol) in 11 mL of methanesulfonic acid, d,l-methionine was added (2.15 g, 14.4 mmol) and the mixture was stirred 24 h at 120 °C. The solution was cooled to room temperature and a solution of NaOH 2 M was added until precipitation. The solid was filtered, dissolved in 6.2 mL of acetic anhydride and pyridine (1.41 mL, 17.5 mmol) was added. The mixture was stirred 22 h at 100 °C. H2O was added (60 mL) and after filtration 9 was obtained as a brown solid (1.79 g) in 87percent yield. Mp: 290 °C (dec.); IR (ATR, ZnSe): ν (cm-1) 2635, 1755, 1682, 1618, 1289, 1217, 918, 833, 674; 1H NMR (400 MHz, DMSO-d6): δ (ppm) 12.21 (br s, 1NH), 8.08 (s, 1H), 7.75 (s, 1H), 7.27 (s, 1H), 3.91 (s, 3H), 2.30 (s, 3H); 13C NMR (126 MHz, DMSO-d6): δ (ppm) 168.7, 159.9, 156.1, 148.9, 145.9, 138.9, 119.1, 115.6, 109.2, 56.5, 20.4; HRMS-ESI calcd for C11H10N2O4 [M+H]+ 235.0713 found 235.0714. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | at 100℃; for 3 h; | (1-3) 7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate; 6.08 g of the compound obtained in (1-2) was dissolved in a mixture of 550 mi of acetic acid and 7 mi of pyridine, and the resulting solution was stirred 100 °C for 3 hours. The reaction solution was cooled to room temperature, and ice was added thereto to induce the crystallization of the product. The solid was filtered under a reduced pressure, washed with water, and air-dried to obtain the title compound (4.87 g, 65percent). 1H-NMR (300MHz, DMSO-d6) δ 12.21 (s, IH), 8.09 (s, IH), 7.76 (s, IH),7.28 (s, IH), 3.91 (s, 3H), 2.30 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: With thionyl chloride In N,N-dimethyl-formamide for 6 h; Reflux Stage #2: With triethylamine In N,N-dimethyl-formamide; isopropyl alcohol at 20℃; for 9 h; Reflux |
General procedure: A mixture of 4-hydroxyquinazolin-6-yl acetate (0.62 g, 3 mmol)and DMF (0.1 mL) in thionyl chloride (10 mL) was stirred underreflux for 6 h and then thionyl chloridewas removed under reducedpressure. To the residue was added isopropanol (20 mL), 3-bromoaniline (0.62 g, 3.6 mmol) and triethylamine (0.36 g,3.6 mmol). The resulting reaction mixture was stirred at roomtemperature for 6 h and then at reflux for another 3 h. After coolingto room temperature, the yellow solid was collected by suckfiltration, wash with isopropanol, water and ether sequentially, anddried at 50 °C to afford compound 12a as a yellow solid (0.74 g, 69percentyield). |
[ 162012-72-8 ]
6-Methoxy-7-hydroxyquinazolin-4-one
Similarity: 0.77
[ 179688-52-9 ]
6-Hydroxy-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77
[ 13794-72-4 ]
6,7-Dimethoxy-1H-quinazolin-4-one
Similarity: 0.77
[ 286371-64-0 ]
6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77
[ 162012-72-8 ]
6-Methoxy-7-hydroxyquinazolin-4-one
Similarity: 0.77
[ 179688-52-9 ]
6-Hydroxy-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77
[ 13794-72-4 ]
6,7-Dimethoxy-1H-quinazolin-4-one
Similarity: 0.77
[ 286371-64-0 ]
6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77
[ 155960-91-1 ]
Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate
Similarity: 0.70
[ 179688-27-8 ]
Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate
Similarity: 0.65
[ 853058-41-0 ]
Ethyl 4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidine-7-carboxylate
Similarity: 0.65
[ 214470-85-6 ]
Methyl 2-amino-5-ethoxy-4-methoxybenzoate
Similarity: 0.64
[ 61032-42-6 ]
Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate
Similarity: 0.64
[ 162012-72-8 ]
6-Methoxy-7-hydroxyquinazolin-4-one
Similarity: 0.77
[ 179688-52-9 ]
6-Hydroxy-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77
[ 13794-72-4 ]
6,7-Dimethoxy-1H-quinazolin-4-one
Similarity: 0.77
[ 286371-64-0 ]
6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one
Similarity: 0.77